West Coast Financial’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-10,619
Closed -$3.46M 140
2021
Q3
$3.46M Buy
10,619
+1
+0% +$339 0.56% 50
2021
Q2
$3.31M Buy
10,618
+166
+2% +$50.9K 0.54% 50
2021
Q1
$3.33M Sell
10,452
-20
-0.2% -$6.4K 0.58% 48
2020
Q4
$3.4M Sell
10,472
-102
-1% -$28.2K 0.65% 46
2020
Q3
$2.93M Sell
10,574
-2,428
-19% -$699K 0.66% 48
2020
Q2
$3.14M Buy
+13,002
New +$2.61M 0.77% 44

Other funds holding ABMD

West Coast Financial's ABMD Position: Q4 2021 in Review

West Coast Financial sold out of Abiomed Inc (ABMD) in Q4 2021, closing a stake of 10,619 shares — an estimated $3.46M sold.

West Coast Financial first reported a position in ABMD in Q2 2020 and held it in 6 quarters. The position peaked at $3.46M in Q3 2021. 496 funds tracked by Wall St. Rank hold ABMD as of Q4 2021.

  • West Coast Financial reported no remaining Abiomed Inc position as of Q4 2021 after selling out during the quarter.
  • West Coast Financial sold 10,619 Abiomed Inc shares in Q4 2021, an estimated $3.46M.
  • West Coast Financial first reported a position in Abiomed Inc in Q2 2020 and held it in 6 quarters.
  • West Coast Financial's Abiomed Inc position peaked at $3.46M in Q3 2021.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2021.

Based on West Coast Financial's 13F filing for Q4 2021, filed 19 Jan 2022.